ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 359239 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 359239; 2) Community: the network communities that were significantly associated with the response to NSC 359239; 3) Molecule: the relationships between components within communities and NSC 359239; 4) MDR: the compounds that were significantly associated with the NSC 359239.

NSC Compound Enrichment Correlation
NSC 328410 Camptothecin Derivative 0.000644707050513007 0.21638482
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.000644707050513007 0.043871333
NSC 31717 Tetraethylenimino-1,4-benzoquinone 0.00078227743523216 -0.050423319
NSC 683584 Null 0.00078227743523216 -0.025389819
NSC 726328 3-Bromo-4-(3,3-dimethyl-but-1-ynyl)-2(5H)-furanone 0.000837923650101952 -0.26733399
NSC 237538 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- 0.000931492155975089 0.065123635
NSC 624902 Null 0.000931492155975116 0.28879662
NSC 656889 XK-469 0.000931492155975116 0.33375559
NSC 666401 2H-Phenanthro[2,1-b]pyran-2-one, 3,4,4a,4b,5,6- 10b,11,12,12a-decahydro-8-methoxy-12a-methyl- 0.000931492155975116 0.12649091
NSC 693984 Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-propynyl-, (E)- 0.000931492155975116 -0.1885004
Total:74  Current:2    [First] [Prev] [Next] [Last]